DESTINY TRIAL (Inspiron x Biomatrix)
Stents Coated With the Biodegradable Polymer on Their Abluminal Faces and Elution of Sirolimus Versus Biolimus Elution for the Treatment of de Novo Coronary Lesions - Destiny Trial
Sponsor: Scitech Produtos Medicos Ltda
This PHASE4 trial investigates Coronary Artery Disease and is currently completed. Scitech Produtos Medicos Ltda leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Apr 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Dec 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE4
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Scitech Produtos Medicos Ltda
For direct contact, visit the study record on ClinicalTrials.gov .